• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

post-transplant lymphoproliferative disorder - Articles and news items

Cancer immunotherapy candidate

Cancer treatment receives EU drug designations

Industry news / 20 July 2016 / Niamh Louise Marriott, Digital Content Producer

With the EU orhpan drug designations, Cell Medica can now obtain regulatory and financial incentives for developing and marketing CMD-003 as a cancer…

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +